Bridging pathologies: Mechanistic insights into the diabetes–Alzheimer's nexus
EXCLI Journal · 23.01.2026 · 25 · 261-289
DOI: 10.17179/excli2025-9165 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift EXCLI Journal, online erschienen am 23.01.2026. Verfasst von Aniket Kakkar und 6 weiteren Autor:innen. Beteiligte Einrichtung: SOS School of Pharmacy (Faculty of Pharmacy), IFTM University, Moradabad, Uttar Pradesh, 244102, India. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz, Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) is increasingly recognized as a major risk factor for Alzheimer's disease (AD), with mounting evidence highlighting shared pathophysiological mechanisms. This review explores the intricate biological and molecular links between these two chronic disorders. Key overlapping pathways include impaired insulin signaling, chronic inflammation, oxidative stress, mitochondrial dysfunction, amyloid-beta (Aβ) accumulation, tau hyperphosphorylation, and the formation of advanced glycation end-products (AGEs). Disruption of insulin signaling in the brain contributes to synaptic loss and neurodegeneration, while systemic metabolic disturbances aggravate blood-brain barrier dysfunction and neurovascular damage. Emerging studies also underscore the role of antidiabetic treatments, especially newer agents targeting the gut-brain axis, in modulating AD progression. The review further examines preclinical models, clinical observations, and the development of biomarkers to improve early detection and intervention. Despite growing insights, challenges remain in translating mechanistic knowledge into effective therapies. A multidisciplinary approach integrating metabolic control and neuroprotective strategies is essential for addressing the comorbid burden of T2DM and AD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- SOS School of Pharmacy (Faculty of Pharmacy), IFTM University, Moradabad, Uttar Pradesh, 244102, India.
- School of Pharmaceutical Sciences (Faculty of Pharmacy), IFTM University, Moradabad, Uttar Pradesh, 244102, India.
- School of Medical & Allied Sciences, K. R. Mangalam University, Gurugram, Haryana, India.
- Department of Biosciences, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, 602105, Tamil Nadu, India.
- Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India.
Zitieren
APA
Kakkar, A., Singh, H., Jasoria, Y., Kumar, A., Chopra, S., Chopra, H., & Mishra, A. K. (2026). Bridging pathologies: Mechanistic insights into the diabetes–Alzheimer's nexus. EXCLI Journal, 25, 261-289. https://doi.org/10.17179/excli2025-9165
Vancouver
Kakkar A, Singh H, Jasoria Y, Kumar A, Chopra S, Chopra H, et al. Bridging pathologies: Mechanistic insights into the diabetes–Alzheimer's nexus. EXCLI Journal. 2026;25:261-289. doi:10.17179/excli2025-9165
BibTeX
@article{Kakkar2026,
author = {Kakkar, Aniket and Singh, Harpreet and Jasoria, Yash and Kumar, Arvind and Chopra, Shivani and Chopra, Hitesh and Mishra, Arun Kumar},
title = {Bridging pathologies: Mechanistic insights into the diabetes–Alzheimer's nexus},
journal = {EXCLI Journal},
year = {2026},
volume = {25},
pages = {261--289},
doi = {10.17179/excli2025-9165}
}
EUVIMED